[1]张晓丽,李晶晶,谭广萍,等.腹腔镜病灶切除联合序贯使用亮丙瑞林及优思明在子宫腺肌病中的应用[J].医学信息,2020,33(03):102-104.[doi:10.3969/j.issn.1006-1959.2020.03.029]
　ZHANG Xiao-li,LI Jing-jing,TAN Guang-ping,et al.The Effect of Sequential Drug Treatment on Adenomyosis After Laparoscopic Focal Resection[J].Medical Information,2020,33(03):102-104.[doi:10.3969/j.issn.1006-1959.2020.03.029]
点击复制

腹腔镜病灶切除联合序贯使用亮丙瑞林及优思明在子宫腺肌病中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年03期
页码:
102-104
栏目:
临床研究
出版日期:
2020-02-01

文章信息/Info

Title:
The Effect of Sequential Drug Treatment on Adenomyosis After Laparoscopic Focal Resection
文章编号:
1006-1959（2020）03-0102-03
作者:
张晓丽; 李晶晶; 谭广萍; 等
（柳州市工人医院妇产科，广西 柳州 545005）
Author(s):
ZHANG Xiao-li; LI Jing-jing; TAN Guang-ping; CEN Fu-zhu
(Department of Obstetrics and Gynecology,Liuzhou Workers’ Hospital,Liuzhou 545005,Guangxi,China)
关键词:
子宫腺肌病; 病灶切除; 腹腔镜; 亮丙瑞林; 优思明
Keywords:
Adenomyosis; Focal resection; Laparoscopy; Leuprolide; Yosmin
分类号:
R711.7
DOI:
10.3969/j.issn.1006-1959.2020.03.029
文献标志码:
A
摘要:
目的 探讨腹腔镜病灶切除术后联合药物序贯治疗子宫腺肌病的效果。方法 选取2015年1月~2018年12月我院收治的子宫腺肌病患者53例，予腹腔镜病灶切除术后序贯使用亮丙瑞林及优思明治疗，比较术前术后血清CA125、血红蛋白含量、痛经VAS评分、经量PBLAC评分、子宫体积，不良反应、复发情况及妊娠结局。结果 53例子宫腺肌瘤患者行腹腔镜病灶切除手术均获成功，手术时间（126.51±41.40）min，术中出血量（168.42±139.61）ml，平均住院（8.00±3.50）d，肛门排气时间（3.41±2.23）d。术后3个月血清CA125低于术前，血红蛋白水平高于术前，差异有统计学意义（P＜0.05）。术后6、12、24、36个月痛经VAS评分、经量PBLAC评分均低于术前、子宫体积小于术前，差异有统计学意义（P＜0.05）；术后6、12、24、36个月痛经VAS评分、经量PBLAC评分、子宫体积比较，差异无统计学意义（P＞0.05）。患者均未出现手术及药物不良反应，未观察到复发病例。15例有生育要求者，2例术后辅助生殖受孕，其中1例单胎妊娠38+1周行剖宫产，分娩一健康婴儿，无胎盘植入。结论 腹腔镜病灶切除术后联合亮丙瑞林及优思明序贯治疗子宫腺肌病患者疗效确切，可有效缓解痛经，改善月经量情况，值得临床应用。
Abstract:
Objective To investigate the effect of sequential drug treatment on adenomyosis after laparoscopic lesion resection.Methods 53 patients with adenomyosis treated in our hospital from January 2015 to December 2018 were treated with leuprolide and yosmin sequentially after laparoscopic lesion resection, and serum CA125 before and after surgery was compared. , Hemoglobin content, dysmenorrhea VAS score, menstrual PBLAC score, uterine volume, adverse reactions, recurrence and pregnancy outcomes.Results Laparoscopic resection of 53 patients with adenomyoma was successfully performed. The operation time was(126.51±41.40) min. The intraoperative blood loss was(168.42±139.61) ml. The average hospitalization was (8.00±3.50) d,anal exhaust time(3.41±2.23) d. The serum CA125 was lower than that before surgery and the hemoglobin level was higher than that before surgery at 3 months after operation,the difference was statistically significant(P<0.05). The dysmenorrhea VAS score and menstrual volume PBLAC scores at 6,12,24 and 36 months after surgery were lower than those before surgery, and the uterine volume was smaller than before surgery,the differences were statistically significant(P<0.05); There were no significant differences in dysmenorrhea VAS score, menstrual volume PBLAC score, and uterine volume at 6,12,24 and 36 months after surgery(P>0.05). None of the patients had surgery or adverse drug reactions, and no recurrence was observed. Fifteen patients had fertility requirements, two were assisted reproductive pregnancy, one of them had a cesarean section with a single pregnancy at 38+1 weeks, and delivered a healthy baby without placental implantation.Conclusion Sequential treatment of leuprolide and yosmin in patients with adenomyosis after laparoscopic focal resection is effective, it can effectively alleviate dysmenorrhea, improve menstrual flow, and is worthy of clinical application.

参考文献/References:

[1]Naftalin J,Hoo W,Nunes N,et al.Association between ultrasound features of adenomyosis and severity of menstrual pain[J].Ultrasound Obstet Gynecol,2016,47(6):779-783. [2]郎景和.重视子宫腺肌病的多元化治疗[J].中华妇产科杂志,2016,51(9):641-642. [3]彭燕蓁,段华,郭银树,等.开腹与腹腔镜子宫腺肌病灶切除术的临床比较[J].中华腔镜外科杂志(电子版),2016,9(6):362-365. [4]彭存旭,李景刚,郝贤华,等.腹腔镜下多术式联合治疗子宫腺肌病的临床观察[J].实用妇产科杂志,2014,30(6):475-478. [5]Gurian MB,Mitidiefi AM,Rosa E Silva JC,et al.Measures used to assess chronic pelvic pain in randomized controlled clinical trials:a systematic review[J].J Eval Clin Pract,2015,21(4):749-756. [6]Hald K,Lieng M.Assessment of periodic blood loss：interindividualand intraindividual variations of pictorial blood loss assessment chartregislrations[J].J Minim lnvasive GynecoI,2014,21(4):662-668. [7]李源,杨隽钧,李晓光,等.达那唑海藻酸钠微球子宫动脉栓塞治疗子宫腺肌症的疗效及安全性探讨[J].生殖医学杂志,2017, 26(7):646-650. [8]Wang PH,Fuh JL,Chao HT,et al.Is the surgical approachbeneficial to subfertile women with symptomatic extensiveadenomyosis[J].J Obstet Gynecol Res,2009,35(3):495-502. [9]Grimbizis GF,Mikos T,Tarlatzis B.Uterus-sparing operativetreatment for adenomyosis[J].Fertil Steril,2014,101(2):472-487. [10]叶明珠,邓新粮,朱小刚,等.高强度聚焦超声消融技术联合GnRH-a及LNG-IUS治疗子宫腺肌病痛经的临床研究[J].中华妇产科杂志,2016,51(9):643-649. [11]Schindler AE.Oral hormonal contraceptives and endometriosis[J].Eur J Contracept Reprod Health Care,2012(17):153-154.

相似文献/References:

[1]翟 蓓,周 洋,周 薇,等.超声检查、磁共振及血清CA125测定诊断 子宫腺肌病的临床评价[J].医学信息,2018,31(11):154.[doi:10.3969/j.issn.1006-1959.2018.11.050]
　ZHAI Bei,ZHOU Yang,ZHOU Wei,et al.Clinical Evaluation of Ultrasonography,Magnetic Resonance Imaging and Serum CA125 in Diagnosis of Adenomyosis[J].Medical Information,2018,31(03):154.[doi:10.3969/j.issn.1006-1959.2018.11.050]
[2]杨 霞,陈亚兰.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].医学信息,2019,32(14):117.[doi:10.3969/j.issn.1006-1959.2019.14.037]
　YANG Xia,CHEN Ya-lan.Clinical Observation of Levonorgestrel Intrauterine Sustained Release System in the Treatment of Adenomyosis[J].Medical Information,2019,32(03):117.[doi:10.3969/j.issn.1006-1959.2019.14.037]
[3]李 娟,胡 欣,张小妹.米非司酮联合血府逐瘀汤治疗子宫腺肌病的临床观察[J].医学信息,2021,34(23):168.[doi:10.3969/j.issn.1006-1959.2021.23.051]
　LI Juan,HU Xin,ZHANG Xiao-mei.Clinical Observation of Mifepristone Combined with Xuefu Zhuyu Decoction in the Treatment of Adenomyosis[J].Medical Information,2021,34(03):168.[doi:10.3969/j.issn.1006-1959.2021.23.051]
[4]彭琼琳,黄 敏.超声消融结合中药治疗子宫腺肌病继发性痛经的效果[J].医学信息,2021,34(17):157.[doi:10.3969/j.issn.1006-1959.2021.17.042]
　PENG Qiong-lin,HUANG Min.The Effect of Ultrasonic Ablation Combined with Traditional Chinese Medicine in the Treatment of Secondary Dysmenorrhea Caused by Adenomyosis[J].Medical Information,2021,34(03):157.[doi:10.3969/j.issn.1006-1959.2021.17.042]
[5]彭琼琳,黄 敏.高强度聚焦超声消融联合当归芍药散治疗子宫腺肌病的疗效分析[J].医学信息,2022,35(01):133.[doi:10.3969/j.issn.1006-1959.2022.01.032]
　PENG Qiong-lin,HUANG Min.Efficacy of High-intensity Focused Ultrasound Ablation Combined with Danggui Shaoyao Powder in the Treatment of Adenomyosis[J].Medical Information,2022,35(03):133.[doi:10.3969/j.issn.1006-1959.2022.01.032]

更新日期/Last Update: 2020-02-01